Growing. That’s how I would describe UVA Cancer Center today. We are growing our faculty and have seen a significant increase in the number of patients that we care for. We are expanding clinical services and creating clinical and research partnerships across the state.
Nowhere is this growth more evident than in our clinical research programs. This year, we will undertake our first CAR T cell clinical trial in pancreatic cancer, with others planned.
Some growth is planned and predictable. At other times, it takes us in unexpected directions. When the Emily Couric Clinical Cancer Center opened five years ago, we felt we had a facility to meet the needs of our patients well into the future. Today, that path has changed dramatically. The number of patients receiving infusions, for example, has quadrupled, driven by new therapies. We will soon begin the expansion of the Couric Center to accommodate further growth.
Other adjustments will come in this time of great advances in cancer care. UVA Cancer Center will continue to grow to meet the needs of all of our patients—those of today and those of tomorrow.
- Robert Dreicer, MD, Deputy Director of UVA Cancer Center